Singapore: A team of scientists at National University of Singapore (NUS) have discovered that a drug originally designe...
Singapore: Singapore and Germany based biotech company, AYOXXA Biosystems, has completed $12.28 million (€9 millio...
Singapore: The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyon...
Singapore: European Commission has approved Janssen-Cilag International's Stelara (ustekinumab), as a stand-alone drug o...
Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announc...
Singapore: German company, Riboxx Pharmaceuticals, received patent from European Patent Office (EPO) on a novel process ...
Singapore: China-based 3SBio, which is focused on R&D, manufacturing and marketing biopharmaceutical products, acqu...
Many companies in India, China and to an extent Korea have established a strong position in contract manufacturing of ac...
Singapore: AB SCIEX, life science analytical technologies provider, has launched StatusScope Remote Monitoring service, ...
Singapore: Global supplier firm, Agilent Technologies, has launched QuikChange HT Protein Engineering System, a novel sy...
Singapore: As a solution to the lack of affordable test tube baby technology in developing countries, Belgian doctors ha...
Singapore: Efficient resource to therapy of complex disorders with lesser side-effects has accelerated growth of monoclo...
Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmac...
Singapore: Global Pharmaceutical company, Merck, and Samsung Bioepis, a joint venture between Samsung Biologics and Biog...
Singapore: Serological tests conducted on poultry workers of southern Guangdong province city of Shenzhen China, showed ...
Singapore: San Francisco-based Ascendancy Healthcare has tied up with Quintiles to get help from the contract research g...
Singapore: Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered the origin of a group of skin-deep...
Singapore: India based Polyclone, a biotech company with expertise in molecular, cell and computational biology has coll...
Singapore: GE Healthcare introduced KUBio, an innovative off-the-shelf, modular factory, designed to save manufacturers ...
Singapore: South Korean company Green Cross is building a plasma derivatives plant (worth $68 million) in Bangkok, Thail...
Singapore: Novozymes reported seven percent sales growth in 2012 when compared with 2011. EBIT increased by 17 percent, ...
In recent years, licensing and quality control for manufacturers and national regulatory authorities has become more com...
Singapore: China based biotech firm, 3SBio, has partnered with Selecta Biosciences to license out pegsiticase (Uricase P...
Singapore: GE Healthcare Life Sciences has launched ReadyToProcess Wave 25, a next-generation, single-use, rocking biore...
Publicly-held biotech company TaiMed Biologics was set up in 2007 with the mission to discover, develop and deliver inno...
Singapore: Australian biotechnology company Minomic is all set to launch two overseas trials of its MiStat prostate canc...
Singapore: Dr Junying Yuan, a pioneer and leading researcher in the field of cell death at the Chinese Academy of Scienc...
Singapore: Samsung BioLogics and Roche have entered into a long term strategic manufacturing agreement under which Samsu...
Singapore: Sanofi and US-based Transgene have launched the construction phase of the manufacturing platform dedicated to...
‎Singapore: US based biosimilar therapeutic developer, Coherus BioSciences, has started its Phase 3 trial of CHS-0...
Singapore: Cell culture is going to become the next big pharmaceutical trend, as laboratories rush to meet demand for st...
Singapore: Austrianova Singapore has established a research cell bank, the first step towards late-phase clinical trials...
Singapore: Genzyme, a Sanofi company, plans to invest USD80 million to build a new downstream processing facility for Fa...
Singapore: Internationally-recognized experts in computing and atmospheric physics, developmental biology, organometalli...
After five years of amendments and two rounds of public consultations, the State Food and Drug Administration (SFDA) iss...
Singapore: Switzerland based EPIRUS, a wholly-owned subsidiary of Boston-based EPIRUS Biopharmaceuticals, and Ranbaxy La...
Singapore: Pharmaceutical Product Development (PPD) has appointed Dr David Johnston as executive vice president of globa...
Singapore: Agilent Technologies and Korea-based Daegu Gyeongbuk Institute of Science and Technology (DGIST) have collabo...
Singapore: Shire, global specialty biopharmaceutical company, has recieved US FDA approval for production of VPRIV drug ...
Singapore: MedImmune, the global biologics R&D arm of AstraZeneca, has entered into a three-year collaboration with ...
Singapore: On January 10 2014, members of Association of Contract Research Organizations (ACRO INDIA) met and Mr D A Pra...
Boston: India has announced the much-awaited new and simple regulatory guidelines for similar biologics which have been...
Singapore: Australia based Admedus has received FDA clearance to market CardioCel in the US. CardioCel is the group's l...
Biologics manufacturers in Asia have to be more vigilant and give higher priority to product safety and product efficacy...
Singapore: Boehringer Ingelheim has developed and implemented a flexible set-up and operational approach for disposable ...
Singapore: The US State of California's biosimilar Senate Bill 598, which is a pharmacy substitution law to allow great...
When it comes to contract biologics manufacturing, despite the increasing opportunities, there is a concern regarding th...
Singapore: Sigma-Aldrich, bioscience and technology company, is set to commercialize a kit for hand-driven, self-encapsu...
Singapore: Autism results from abnormal cell communication. Testing a new theory, researchers at the University of Calif...
Singapore: Research from University of Adelaide have shown that immune cells known as macrophages are critical to fertil...
Singapore: GE Healthcare Life Sciences has tied up with Osaka University to allow students to have access to GE Healthca...
Singapore: SGX-listed Luye Pharma Group is investing S$6 million (A$4.6 million) in NuSep's Singapore subsidiary Prime B...
Singapore: Merck Millipore, the life science division of Merck, launched Mobius FlexReady Solution with Smart Flexware A...
Singapore: AB Sciex, a global leader in analytical technologies, has launched a breakthrough technology solution called ...
Singapore: GlobalFiler Express Kit by Life Technologies has been approved by the United States Federal Bureau of Investi...
Singapore: The US Food and Drug Administration (FDA) has accepted Australia-based CSL Behring's biologics license applic...
Entry of multinational companies has been a big boost to Asia's position in biologics manufacturing, especially with cGM...
Singapore: US based Targos, clinical biomarker service provider has signed a collaboration deal with China's WuXi Pharma...
Singapore: Boehringer Ingelheim is closing down its generic sterile injectables manufacturing arm, Ben Venue Laboratorie...
Singapore: Agilent Technologies and US-based SomaLogic have entered into an agreement to expand access to SomaLogic's un...
Singapore: Novartis is investment over $500 million for a new state-of-the-art biotechnology production site in Singapor...
Singapore: Institute for Systems Biology (ISB) and AB SCIEX have signed a multi-year agreement to collaborate on the dev...
Singapore: Two studies by Roche has demonstrated that a fixed dose of MabThera (rituximab) can be administered subcutane...
Singapore: Merck Millipore, the life science division of Merck, and the Institute of Bioprocess Engineering and Pharmace...
Singapore: A team of scientists from A*STAR's Institute of Medical Biology (IMB) and Genome Institute of Singapore (GIS)...
Singapore: China is soon expected to become a sales hub for lab analytical instruments as international companies speed ...
Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, will rel...
Singapore: Germany-based Oncotest and Debiopharm, a Swiss-based global biopharmaceutical group, have completed first bio...
Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorization for Merck Sharp And Dohme'...
Singapore: US-based Intrexon, a synthetic biology company, has appointed Dr Peter Seufer-Wasserthal as VP, business deve...
Singapore: China Biologic Products reported its unaudited financial results for the second quarter of 2013. Total sales ...
Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announce...
Singapore: GE Healthcare has launched Biacore T200 Software v.2.0, offering researchers a flexible and powerful tool for...
Singapore: AyoxxA Biosystems, an international biotechnology company, has closed a $3.37 million (2.6 million Euro) seri...
Singapore: China based emerging biopharmaceutical company, JHL Biotech, has closed a Series B financing round of $35 mil...
Singapore: BioCSL has inked a deal with US-based Immucor to distribute transfusion testing technology in Australia and N...
Singapore: Promega opened a new facility in Shanghai for its China operations. The new site for Shanghai Promega Biologi...
Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI) at National University of Singapore (NU...
Singapore: China Biologic Products, one of the leading plasma-based biopharmaceutical companies in China, has appointed ...
Singapore: Japan-based global analytics technology provider, Shimadzu, has launched i-Series of new industry standard HP...
Singapore: Singapore's Clearbridge BioMedics has closed a $7.2 million (S$9 million) Series B financing, led by Vertex V...
Singapore: Agilent Technologies has launched Encore Multispan Liquid Handling System, featuring an array of unique techn...
Traditionally, researchers have utilized rodents to generate antibodies that attack human cancer tissues. In most cases,...
Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a research and development outsourcing c...
Singapore: Research based pharmaceutical company, AbbVie, has made investment of around USD320 million in Singapore to s...
Singapore: Scientists from Institute of Molecular and Cell Biology (IMCB), a research institute under the Agency for Sci...
Singapore: Life science analytical technologies company, AB Sciex, has launched the second generation TripleTOF 5600 Sys...
Singapore: Professor Wang Yue from A*STAR's Institute of Molecular and Cell Biology (IMCB) received the President's Scie...
‎Singapore: Professor Ding Kan's research team members from Shanghai Institute of Materia Medica, Chinese Academy ...
Singapore: WuXi AppTec has invested substantially in building its capabilities and capacity in biologics in the past fe...
Singapore: Biologics World Korea, which attracted over 130 biologics industry leaders in 2012, has decided to conduct th...
Singapore: NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic...
Singapore: Researchers at Institute of Bioengineering and Nanotechnology (IBN), Singapore have developed a genetic test ...
Singapore: Scientists at A*Star's Genome Institute of Singapore (GIS) and US-based Stanford University's School of Medic...
Singapore: AB SCIEX launched a new application called LibraryView Software that enables faster and more reliable identif...
Singapore: Singapore based biotechnology firm, Austrianova, has received Board of Investment (BOI) status for its Thai s...
Singapore: Australian regenerative medicine firm, Orthocell, is looking ahead to raise $8 million through an Initial Pub...
One of the biggest challenges in developing and manufacturing antibodies is proving the equivalence or similarity to the...
Singapore: China Biologic Products, a plasma-based biopharmaceutical company in China, has marked sales growth of 6.2 pe...
Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the ...
